← Leaderboards
Ren Sun
University Of California Los Angeles
$20,189,518
Attributed
$21,643,268
Total exposure
21
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$36,758,617 · 23
By mechanism
P01$19,239,941 · 7
R01$11,751,167 · 7
T32$2,535,526 · 1
R21$2,219,984 · 6
RC2$999,999 · 1
R13$12,000 · 1
Top collaborators
- Z Hong Zhou5 shared
- Marcia A Blackman2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ronald T Mitsuyasu$121,811,876
- Mo Kwan Kang$3,420,661
- Stephen T Smale$23,431,293
- Genhong Cheng$27,178,241
Others in their field
Top investigators on “Human Herpesvirus 8”
- David Heimbrook · Leidos Biomedical Research, Inc.$188,989,000
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Jae U Jung · Cleveland Clinic Lerner Com-Cwru$44,754,023
- Scott W Wong · Oregon Health And Science University$28,229,656
- Blossom A Damania · University Of North Carolina Chapel Hill$27,475,432
Research focus
Human Herpesvirus 8VirusViralHerpesviridaeMalignant NeoplasmsInfectionProteinsCellsGammaherpesvirusProgramsIn VivoKaposi SarcomaTumorProductionImmune ResponseHuman Herpesvirus 4ImmuneSignal TransductionVaccinesGenesMutantHerpesviridae InfectionsResponseMember
Grant awards (103)
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid$367,501
R01 · FY2020 · DE
Structure-guided development of chemical inhibitors against Kaposiâs sarcoma-associated herpesvirus (KSHV)$169,650
R21 · FY2020 · CA · contact PI
Mechanism for anti-interferon functions of influenza virus$390,000
R01 · FY2019 · AI · contact PI
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid$385,000
R01 · FY2019 · DE
Structure-guided development of chemical inhibitors against Kaposiâs sarcoma-associated herpesvirus (KSHV)$203,580
R21 · FY2019 · CA · contact PI
Viral Genetics Core$173,126
P01 · FY2019 · AI · contact PI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses$1,766,851
P01 · FY2018 · CA · contact PI
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid$385,000
R01 · FY2018 · DE
Administrative Service$261,448
P01 · FY2018 · CA · contact PI
Viral Genetics Core$175,402
P01 · FY2018 · AI · contact PI
In vivo Interactions Between a Gamma-Herpesvirus and Innate Immune Responses$157,008
P01 · FY2018 · CA · contact PI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses$1,778,661
P01 · FY2017 · CA · contact PI
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid$385,000
R01 · FY2017 · DE
Develop a therapeutic vaccine approach by removing viral immune evasion$385,000
R01 · FY2017 · DE · contact PI
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus$284,547
R01 · FY2017 · CA · contact PI
Administrative Service$261,449
P01 · FY2017 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$252,476
T32 · FY2017 · AI · contact PI
Viral Genetics Core$177,101
P01 · FY2017 · AI · contact PI
In vivo Interactions Between a Gamma-Herpesvirus and Innate Immune Responses$157,010
P01 · FY2017 · CA · contact PI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses$1,728,354
P01 · FY2016 · CA · contact PI
Develop a therapeutic vaccine approach by removing viral immune evasion$385,000
R01 · FY2016 · DE · contact PI
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid$385,000
R01 · FY2016 · DE
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus$284,547
R01 · FY2016 · CA · contact PI
Administrative Service$261,449
P01 · FY2016 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$247,111
T32 · FY2016 · AI · contact PI
In vivo Interactions Between a Gamma-Herpesvirus and Innate Immune Responses$157,010
P01 · FY2016 · CA · contact PI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses$1,743,351
P01 · FY2015 · CA · contact PI
Develop a therapeutic vaccine approach by removing viral immune evasion$385,000
R01 · FY2015 · DE · contact PI
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus$284,547
R01 · FY2015 · CA · contact PI
Administrative Service$254,783
P01 · FY2015 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$241,478
T32 · FY2015 · AI · contact PI
Fitness Profile of HIV-1 Genome with Host Cofactor Selection Pressure$231,000
R21 · FY2015 · AI · contact PI
Functional Profiles of Hepatitis C Virus Genome at Single Nucleotide Resolution$200,970
R21 · FY2015 · CA · contact PI
In vivo Interactions Between a Gamma-Herpesvirus and Innate Immune Responses$150,343
P01 · FY2015 · CA · contact PI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses$1,732,435
P01 · FY2014 · CA · contact PI
Develop a therapeutic vaccine approach by removing viral immune evasion$385,000
R01 · FY2014 · DE · contact PI
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus$276,011
R01 · FY2014 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$238,069
T32 · FY2014 · AI · contact PI
Fitness Profile of HIV-1 Genome with Host Cofactor Selection Pressure$192,500
R21 · FY2014 · AI · contact PI
In vivo Interactions Between a Gamma-Herpesvirus and Innate Immune Responses$176,911
P01 · FY2014 · CA · contact PI
Functional Profiles of Hepatitis C Virus Genome at Single Nucleotide Resolution$167,475
R21 · FY2014 · CA · contact PI
Administrative Service$90,208
P01 · FY2014 · CA · contact PI
Develop a therapeutic vaccine approach by removing viral immune evasion$385,000
R01 · FY2013 · DE · contact PI
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus$284,547
R01 · FY2013 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$224,709
T32 · FY2013 · AI · contact PI
Deregulation of host functions and persistence of KSHV$1,160,373
P01 · FY2012 · DE · contact PI
Inhibition of Interferon Production by KSHV ORF36$235,888
P01 · FY2012 · DE · contact PI
Interdisciplinary Training in Virology and Gene Therapy$214,410
T32 · FY2012 · AI · contact PI
Adminitrative Core-Deregulation of Host Functions and Persistence of KSHV$74,535
P01 · FY2012 · DE · contact PI
Deregulation of host functions and persistence of KSHV$1,195,187
P01 · FY2011 · DE · contact PI
Reactivation of Kaposi's sarcoma-associated herpesvirus$273,019
R01 · FY2011 · CA · contact PI
Inhibition of Interferon Production by KSHV ORF36$242,962
P01 · FY2011 · DE · contact PI
Interdisciplinary Training in Virology and Gene Therapy$227,028
T32 · FY2011 · AI · contact PI
Quantitative High-Resolution Genetic Profiling of a Gammaherpesvirus$190,575
R21 · FY2011 · AI · contact PI
Adminitrative Core-Deregulation of Host Functions and Persistence of KSHV$76,774
P01 · FY2011 · DE · contact PI
Deregulation of host functions and persistence of KSHV$1,243,837
P01 · FY2010 · DE · contact PI
Immunogenicity and efficacy of genetically engineered gamma-herpesvirus vaccines$500,000
RC2 · FY2010 · CA
Reactivation of Kaposi's sarcoma-associated herpesvirus$281,463
R01 · FY2010 · CA · contact PI
Inhibition of Interferon Production by KSHV ORF36$252,779
P01 · FY2010 · DE · contact PI
Interdisciplinary Training in Virology and Gene Therapy$237,876
T32 · FY2010 · AI · contact PI
Quantitative High-Resolution Genetic Profiling of a Gammaherpesvirus$231,000
R21 · FY2010 · AI · contact PI
Adminitrative Core-Deregulation of Host Functions and Persistence of KSHV$79,876
P01 · FY2010 · DE · contact PI
The 13th international Workshop on KSHV and Related Agents$12,000
R13 · FY2010 · CA · contact PI
Deregulation of host functions and persistence of KSHV$1,258,227
P01 · FY2009 · DE · contact PI
Immunogenicity and efficacy of genetically engineered gamma-herpesvirus vaccines$499,999
RC2 · FY2009 · CA
Reactivation of Kaposi's sarcoma-associated herpesvirus$281,463
R01 · FY2009 · CA · contact PI
Inhibition of Interferon Production by KSHV ORF36$255,333
P01 · FY2009 · DE · contact PI
Interdisciplinary Training in Virology and Gene Therapy$230,748
T32 · FY2009 · AI · contact PI
Adminitrative Core-Deregulation of Host Functions and Persistence of KSHV$80,682
P01 · FY2009 · DE · contact PI
Deregulation of host functions and persistence of KSHV$1,271,573
P01 · FY2008 · DE · contact PI
Inhibition of Interferon Production by KSHV ORF36$291,833
P01 · FY2008 · DE · contact PI
Reactivation of Kaposi's sarcoma-associated herpesvirus$281,463
R01 · FY2008 · CA · contact PI
Deregulation of host functions and persistence of KSHV$236,500
P01 · FY2008 · DE · contact PI
Interdisciplinary Training in Virology and Gene Therapy$212,281
T32 · FY2008 · AI · contact PI
Viral Genes Essential for MHV-68 Persistent Infection in the Spleen$172,052
R21 · FY2008 · CA · contact PI
Genome-wide identification of suppressors of KSHV reactivation$144,565
R21 · FY2008 · CA · contact PI
Adminitrative Core-Deregulation of Host Functions and Persistence of KSHV$80,682
P01 · FY2008 · DE · contact PI
Role of Interleukin-6 in Gammaherpesvirus replication$309,264
R01 · FY2007 · DE · contact PI
Reactivation of Kaposi's sarcoma-associated herpesvirus$281,463
R01 · FY2007 · CA · contact PI
Interdisciplinary Training in Virology and Gene Therapy$209,340
T32 · FY2007 · AI · contact PI
Genome-wide identification of suppressors of KSHV reactivation$175,465
R21 · FY2007 · CA · contact PI
Viral Genes Essential for MHV-68 Persistent Infection in the Spleen$141,152
R21 · FY2007 · CA · contact PI
Role of Interleukin-6 in Gammaherpesvirus replication$318,501
R01 · FY2006 · DE · contact PI
Role of Interleukin-6 in Gammaherpesvirus replication$325,994
R01 · FY2005 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$285,728
R01 · FY2005 · CA
Reactivation of Kaposi's sarcoma associated herpesvirus$46,489
R01 · FY2005 · CA
Role of Interleukin-6 in Gammaherpesvirus replication$323,931
R01 · FY2004 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$285,728
R01 · FY2004 · CA
Viral Lysis of Kaposi's Sarcoma Tumor Cells$274,500
R01 · FY2004 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$46,188
R01 · FY2004 · CA
Role of Interleukin-6 in Gammaherpesvirus replication$322,041
R01 · FY2003 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$285,728
R01 · FY2003 · CA
Viral Lysis of Kaposi's Sarcoma Tumor Cells$274,500
R01 · FY2003 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$42,639
R01 · FY2003 · CA
Reactivation of Kaposi's sarcoma associated herpesvirus$285,728
R01 · FY2002 · CA
Viral Lysis of Kaposi's Sarcoma Tumor Cells$274,725
R01 · FY2002 · DE
Reactivation of Kaposi's sarcoma associated herpesvirus$285,728
R01 · FY2001 · CA
Viral Lysis of Kaposi's Sarcoma Tumor Cells$229,527
R01 · FY2001 · DE
POLYADENYLATED NUCLEAR RNA OF HUMAN HERPESVIRUS-8$205,211
R01 · FY2001 · CA
POLYADENYLATED NUCLEAR RNA OF HUMAN HERPESVIRUS-8$37,945
R01 · FY2001 · CA
POLYADENYLATED NUCLEAR RNA OF HUMAN HERPESVIRUS-8$29,261
R01 · FY2001 · CA
Reactivation of Kaposi's sarcoma associated herpesvirus$27,008
R01 · FY2001 · CA
POLYADENYLATED NUCLEAR RNA OF HUMAN HERPESVIRUS-8$199,232
R01 · FY2000 · CA